Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Rentschler Biopharma SE
Sort By
Newest First
Sign in
1 / 2
1 / 2
AAV Quality
Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation
Nathan Sweeney, Ph.D.; Hena Divanovic, M.Sc.
Rentschler Biopharma SE
PAO-11-24-CL-06
Dec 02, 2024
PPQ
Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months
Jessica Feldman, Ph.D.; Henning Gerschewski
Rentschler Biopharma SE
PAO-10-24-CL-12
Dec 02, 2024
Expansion
Building on a Pioneering Biomanufacturing Legacy with Client Centricity
Benedikt von Braunmühl; Tom Roberts
Rentschler Biopharma SE
PAO-09-24-CL-05
Sep 09, 2024
Real-World Data
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
Pharma's Almanac
PAO-09-23-RT-01
Sep 15, 2023
Industry Wisdom
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
Pharma's Almanac
PAO-09-23-RT-02
Sep 15, 2023
Unmet Needs
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Pharma's Almanac
PAO-06-022--RT-01
Jun 24, 2022
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01
Jun 24, 2022
Strategic Alliance
Rentschler Biopharma and Vetter Unveil Xpert Alliance
Rentschler Biopharma SE
PR-M03-22-14
Mar 29, 2022
Biopharmaceutical Manufacturing
Investing and Expanding for High-Quality Biopharmaceuticals
Rentschler Biopharma SE
PAO-02-22-R250-19
Feb 24, 2022
Integrated Services
Collaborating Strategically and Leveraging Innovation to Drive Success
Federico Pollano
Rentschler Biopharma SE
PAO-10-21-CL-18
Nov 22, 2021
Collaboration
Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development
Peter Soelkner
Vetter Pharma International GmbH
PAO-06-21-CL-02-954
Jun 09, 2021
Vetter and Rentschler Biopharma Further Strengthen Their Strategic Alliance
Rentschler Biopharma SE
PR-M04-21-028
Apr 28, 2021
Cover Story
Facing the Challenges of the COVID-19 Pandemic: Rentschler Biopharma
Rentschler Biopharma SE
PAP-Q4-20-CL-028
Dec 09, 2020
Industry Leader
Shaping the Future of Biopharma Through Next-Generation Contract Drug Manufacturing
Frank Mathias, Ph.D.
Rentschler Biopharma SE
PAP-Q4-20-CL-023
Dec 09, 2020
Collaboration
Better Together: Collaborating to Simplify Complexities in Drug Development
Peter Soelkner; Frank Mathias, Ph.D.
Vetter Pharma International GmbH
PAP-Q3-20-CL-028
Sep 29, 2020
Collaboration
The Key to Tackling Drug Development Complexity: Collaboration
Rentschler Biopharma SE
PR-M07-20-NI-005
Jul 07, 2020
Collaboration
Rentschler Biopharma Extends Collaboration with Genmab to U.S. Facility
Rentschler Biopharma SE
PR-M05-20-NI-038
May 27, 2020
CDMO Leadership
A Vision for Achieving Worldwide Biopharmaceutical CDMO Leadership
Frank Mathias, Ph.D.
Rentschler Biopharma SE
PAP-Q1-20-CL-003
Mar 19, 2020
Innovation
Driving Innovation to Support Strategic Client Partnerships
Federico Pollano
Rentschler Biopharma SE
PAP-Q2-2019-CL-028
May 24, 2019
Benefitting U.S. Clients
Rentschler Biopharma SE Sets Foot in the U.S. to Strengthen its World-Class CDMO Position
Federico Pollano
Rentschler Biopharma SE
PAP-Q1-2019-CL-033
Mar 12, 2019
